Cargando…

Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study

RATIONALE: Unlike many other COPD studies, the 4-year UPLIFT trial permitted inhaled corticosteroid (ICS) use during run-in and treatment phases. This provided the opportunity to prospectively observe the continuing effects of ICS on respiratory events in closely observed COPD population. OBJECTIVES...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morjaria, Jaymin B., Rigby, Alan, Morice, Alyn H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	COPD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437199/ https://www.ncbi.nlm.nih.gov/pubmed/28255905 http://dx.doi.org/10.1007/s00408-017-9990-8

Ejemplares similares

Continuous Cough Monitoring Using Ambient Sound Recording During Convalescence from a COPD Exacerbation
por: Crooks, Michael G., et al.
Publicado: (2017)

Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations
por: Crooks, Michael G., et al.
Publicado: (2021)

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study
por: Kardos, Peter, et al.
Publicado: (2020)

Symptoms and exacerbations in asthma: an apparent paradox?
por: Morjaria, Jaymin B., et al.
Publicado: (2019)

Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
por: Pini, Laura, et al.
Publicado: (2022)

Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
por: Böcskei, Renáta M., et al.
Publicado: (2019)

Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD
por: Jabbal, Sunny, et al.
Publicado: (2017)

Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Chen, Zhixiang, et al.
Publicado: (2022)

Risk of Readmission and Mortality Following Hospitalization with Hypercapnic Respiratory Failure
por: Meservey, Amber J., et al.
Publicado: (2019)

Determining Static Hyperinflation in Patients with Severe Emphysema: Relation Between Lung Function Parameters and Patient-Related Outcomes
por: de Weger, Wouter W., et al.
Publicado: (2020)

IL-8 Gene Variants and Expression in Childhood Asthma
por: Charrad, Rihab, et al.
Publicado: (2017)

Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD
por: Footitt, Joseph, et al.
Publicado: (2016)

The Relationship Between Cough Reflex Sensitivity and Exacerbation Frequency in Chronic Obstructive Pulmonary Disease
por: Cho, Peter S. P., et al.
Publicado: (2020)

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
por: Tashkin, Donald P., et al.
Publicado: (2018)

Decreased Serum Sirtuin-1 in COPD
por: Yanagisawa, Satoru, et al.
Publicado: (2017)

Tailoring of corticosteroids in COPD management
por: De Coster, Daan A., et al.
Publicado: (2014)

Chronic Cough in Musculoskeletal disorders: Using high resolution oesophageal manometry in search of an Aetiology
por: Pathmanathan, Sega, et al.
Publicado: (2012)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review
por: Tabyshova, Aizhamal, et al.
Publicado: (2021)

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)

Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers
por: Yang, Lucy, et al.
Publicado: (2017)

An audit of COPD: diagnosis and management in general practice
por: Hamad, Ghassan, et al.
Publicado: (2020)

Clinical Consequences of COVID-19 Lockdown in Patients With COPD: Results of a Pre-Post Study in Spain
por: González, Jessica, et al.
Publicado: (2021)

Dietary intervention in the treatment of patients with cough and symptoms suggestive of airways reflux as determined by Hull airways Reflux Questionnaire
por: Smith, Joanna Elizabeth, et al.
Publicado: (2013)

Predictors of Successful Weaning from Noninvasive Ventilation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Single-Center Retrospective Cohort Study
por: Yu, Jie, et al.
Publicado: (2021)

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT
por: Putcha, Nirupama, et al.
Publicado: (2022)

Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD
por: Prakash, Anoop, et al.
Publicado: (2015)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Serum Copper-to-Zinc Ratio and Risk of Chronic Obstructive Pulmonary Disease: A Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2022)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
por: Janson, Christer, et al.
Publicado: (2017)

Radiographic Phenotypes Affect the Risk of Inhaled Corticosteroid-Associated Pneumonia in Patients with COPD
por: Lee, Hyo Jin, et al.
Publicado: (2022)

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT(®) Trial
por: Halpin, David M. G., et al.
Publicado: (2011)

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
por: Yang, Hsi-Hsing, et al.
Publicado: (2017)

Longitudinal Effects of 1-Year Smoking Cessation on Human Bronchial Epithelial Transcriptome
por: Rathnayake, Senani N.H., et al.
Publicado: (2023)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023)

Comparison of Multiple Diagnostic Tests to Measure Dynamic Hyperinflation in Patients with Severe Emphysema Treated with Endobronchial Coils
por: van Dijk, Marlies, et al.
Publicado: (2021)

Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers
por: Jansen, Evalyne M., et al.
Publicado: (2021)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q70h0c43d2ofkb9kb3q2111gkl